Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50years of age: a systematic review and meta-analysis

Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for... J Cancer Res Clin Oncol (2017) 143:1853–1864 DOI 10.1007/s00432-017-2429-z ORIGINAL ARTICLE – CLINICAL ONCOLOGY Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta‑analysis 1,3 1,3 2,3 2,3 2,3 Zhi‑hui Zhang · Xin‑yue Lian · Dong‑ming Yao · Pin‑fang He · Ji‑chun Ma · 2,3 2,3 1,3 2,3 1,3 Zi‑jun Xu · Hong Guo · Wei Zhang · Jiang Lin · Jun Qian Received: 3 January 2017 / Accepted: 18 April 2017 / Published online: 3 May 2017 © Springer-Verlag Berlin Heidelberg 2017 Abstract significantly statistical difference achieved between Purpose A systematic review and meta-analysis were MDS and AML patients in 1-year EFS and NRM [rela- performed to explore the efficacy and safety of allogeneic tive risk (RR) 0.91, 95% CI 0.80–1.04; P = 0.172 and RR hematopoietic stem cell transplantation with a reduced 1.18, 95% CI 0.82–1.69; P = 0.365]. The patients with intensity conditioning regimen in elderly patients with lower diseases risk had the possibility of higher OS rate myelodysplastic syndrome (MDS) or acute myeloid leuke- at ≥ 3 years than those with higher diseases risk (RR 1.37, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cancer Research and Clinical Oncology Springer Journals

Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50years of age: a systematic review and meta-analysis

Loading next page...
 
/lp/springer_journal/reduced-intensity-conditioning-of-allogeneic-hematopoietic-stem-cell-xxraAW0uoN
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Oncology; Cancer Research; Internal Medicine; Hematology
ISSN
0171-5216
eISSN
1432-1335
D.O.I.
10.1007/s00432-017-2429-z
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial